Ilaris is an anti-inflammatory medication indicated for the treatment of inflammatory autoimmune diseases, such as multisystem inflammatory disease or juvenile idiopathic arthritis, for example.
Its active ingredient is canaquinumab, a substance that inhibits the action of an important protein in inflammatory processes, being therefore able to control and alleviate the symptoms of inflammatory diseases where there is excessive production of this protein.
Ilaris is a medicine produced by Novartis laboratories that can only be administered in the hospital and is therefore not available in pharmacies.
Price
The treatment with Ilaris has an approximate price of 60 thousand reais for each 150 mg vial, however, in most cases, it can be obtained for free through SUS.
What it is indicated for
Ilaris is indicated for the treatment of periodic syndromes associated with cryopyrin, in adults and children, such as:
- Familial autoinflammatory syndrome triggered by cold, also called cold urticaria; Muckle-Wells syndrome; Multisystemic inflammatory disease of neonatal onset, also known as Chronic-infantile-neurological-cutaneous-articular syndrome.
In addition, this medication can also be used to treat systemic juvenile idiopathic arthritis in children over 2 years old who have not had good results with treatment with non-steroidal anti-inflammatory drugs and systemic corticosteroids.
How to use
Ilaris is injected into the fatty layer under the skin and can only be administered by a doctor or nurse at the hospital. The dose should be appropriate to the problem and the person's weight, the general guidelines being:
- 50 mg for patients over 40 kg. 2 mg / kg for patients weighing between 15 kg and 40 kg.
The injection should be done every 8 weeks, especially in the treatment of periodic syndromes associated with cryopyrin, during the time recommended by the doctor.
Possible side effects
The most common side effects of this medication include fever, sore throat, thrush, dizziness, dizziness, coughing, difficulty breathing, wheezing or foot pain.
Who should not use
Ilaris should not be used in children under 2 years of age or in people who are hypersensitive to any of its active components. In addition, it should be used with caution in patients with infections or who have infections easily, as this medication increases the risk of having infections.
